RankingsPricing
  1. JP-listed companies
  2. RaQualia Pharma Inc.
  3. Financials
  4. Total liabilities

RaQualia Pharma Inc.【JP:4579】

Market cap
¥22.3B
P/E ratio
-313.5x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal liabilities (Million JPY)YoY (%)
Dec 31, 20244,085+443.56%
Dec 31, 2023752-1.20%
Dec 31, 2022761+70.48%
Dec 31, 2021446+85.83%
Dec 31, 2020240+11.20%
Dec 31, 2019216+10.60%
Dec 31, 2018195+10.77%
Dec 31, 2017176-23.80%
Dec 31, 2016231-2.72%
Dec 31, 2015238-35.85%
Dec 31, 2014371

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)